FDA Inspection
LNK International, Inc.LNK International, Inc. – FDA Inspection, Jun 14, 2013
Record Details
This FDA Inspection record concerns LNK International, Inc., with an inspection on June 14, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- LNK International, Inc.
- Inspection Date
- June 14, 2013
- Product Type
- Drugs
View Company Profile
ID · 3c254484-8702-4348-9cc6-63cceff1dfd0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 831580
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.80(c)(2)(ii)(A)Incomplete periodic safety report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LNK International, Inc.
16| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2026 | Not classified | New York District Office | |
| October 28, 2025 | VAI | New York District Office | Drug Quality Assurance |
| July 1, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for LNK International, Inc.
- FDA Inspection 1288018 - 2026-08-27
- FDA Inspection 1281600 - 2025-10-28
- FDA Inspection 1145956 - 2021-07-01
- FDA Inspection 1078694 - 2019-02-08
- FDA Inspection 1007918 - 2017-03-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.